Due to the COVID-19 pandemic, we have temporarily halted screening for new patients and healthy volunteers. If you are interested in participating in future clinical trials, please register using the volunteer form, and you will be contacted as soon as screening resumes.
F.P. Clinical Pharma has received the authorization from Argentinian MoH - A.N.M.A.T., for the execution of clinical studies in the area of Pharmacokinetics, Phase 1, Bioavailability and Bioequivalence at its Clinical - Pharmacokinetic Research Unit.
Argentinian MoH [I.N.A.M.E.; A.N.M.A.T.] has inspected and authorized the Bioanalytic Laboratories that work for F.P. Clinical Pharma for the development and validation of bioanalytical methods for analite/s quantification.
Authorized by Chile MoH – I.S.P.; as a Center for conducting Bioequivalence Studies with recognition in that country.
Therefore; FP Clinical Pharma’s studies are recognized by the Health Authority of Chile and are accepted to support medicinal products registration.
The authorization is valid for 3 years.
Santiago, Chile, September 5, 2011:-The National Agency of Drugs, Institute of Public Health of Chile through Exempt Resolution #1660 recognized for F.P. Clinical Pharma SRL as a CENTER OF BIOEQUIVALENCE STUDIES for the conduction of clinical, bioanalysis (analysis of drugs in biological fluids) and statistics (statistical analysis/ pharmacokinetics) of studies in bioequivalence.